Roundtable: learnings in practice

27 August 2018 (19:10 - 19:35)

Organised by:

Video

Sign in to view the resources

Slides

About the speakers

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

Professor Andreas Michael Zeiher

Institute of Cardiovascular Regeneration, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail

Welcome and introduction - Highlights from the latest ODYSSEY OUTCOMES data

Professor A. Zeiher (Frankfurt, DE)

Presentation thumbnail

Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: post- ACS patients with elevated atherogenic lipid levels

Professor P. Steg (Paris, FR)

Presentation thumbnail

Learnings from the latest PCSK9i results and and profiles of patients who may benefit the most: efficacy and safety of alirocumab in ODYSSEY OUTCOMES patients with diabetes

Professor K. Ray (London, GB)

Presentation thumbnail

Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: a comprehensive review of the latest lipid lowering therapies outcomes data

Professor C. Cannon (Boston, US)

Presentation thumbnail

Clinical implications for post-ACS patients

Doctor S. Goodman (Toronto, CA)

Access the full session

Session thumbnail

Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data

The Event

ESC Congress 2018

27 August 2018 19:10 CET

You may be interested in

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Webinar

Risk assessment and lipid management in primary prevention

Congress Presentation

State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources